David Crawford, MD
Department of Urologic Oncology
Researcher-physician E. David Crawford has devoted his career in medicine to educating the public about men’s health issues and finding effective techniques and procedures to address prostate cancer, the most common malignancy affecting men in the United States. A graduate of the University of Cincinnati’s College of Medicine, Crawford is a professor of surgery, professor of urology, professor of radiation oncology and head of the section of urologic oncology at the University of Colorado Anschutz Medical Campus in Denver, Colorado.
An active clinician, researcher and educator, Crawford has received more than 95 research grants advancing the diagnosis and treatment of prostate cancer, including metastatic and castrate resistant disease, along with benign prostatic hyperplasia, advanced bladder cancer and other areas of urological infection and malignancies. Crawford has authored or co-authored more than 600 published articles, contributed to 100 educational books, editor of 7 textbooks, and provided more than 1,100 educational talks for patients and physicians. In an effort to raise public awareness about prostate health, Crawford in 1989 founded the Prostate Conditions Education Council (PCEC). The non-profit organization is comprised of a consortium of leading physicians, health educators, scientists and men’s health advocates. PCEC’s advocacy for free or low-cost prostate screening has affected the lives of millions of American men. Dr. Crawford currently chairs the PCEC.
Crawford is an active member of many national and international organizations, including the American Society of Clinical Oncology, American Urological Association (AUA), and the American Association for the Advancement of Science. Within the AUA, he has been a member of the Committee to Study Urologic Research Funding and the Prostate Cancer Clinical Trials subcommittee. Crawford served on the board of governors, the scientific advisory board of the Southwest Oncology Group, and was chairman of the Genitourinary Cancer Committee for 27 years. This group is the largest clinical trials group in the world.
Crawford’s involvement in the national prostate cancer arena has been widely recognized. He has received many honors and awards, including the CAP Cure Annual Award for Scientific Presentation in 1999. In 1997, he was presented with a “Freddie Award” at the AMA International Health and Medical Film Competition for the program, ITV: The Cutting Edge Medical Report (Prostate Cancer: Understanding, Diagnosing, and Defeating), which Crawford hosted with special guest, retired General Norman Schwarzkopf.
Crawford again won a prestigious “Freddie Award” 5 years ago. He is a member of Best Doctors of America and was named Healthcare Provider of the Year in the Denver Metro area by the Denver Business Journal.
It is with the conviction of Marc Bingham, a renowned businessman and philanthropist, that we are able to pursue the goals of research, treatment and education.
Francisco La Rosa, MD, FCAP
For more than 20 years Dr. La Rosa has been a Board Certified pathologist and academician with special training in the sub-specialty of Uro-Pathology. As a Teaching Scholar, he has taught hundreds of medical students, residents and fellows at the University of Colorado. He is very active in the international medical community and is President of the Ibero-American Association of Telehealth and Telemedicine, along with many other leadership positions including Honorary Professor at the National University “Federico Villarreal” in Lima, Peru, Editorial Board Member of the International Journal of Clinical and Experimental Pathology and Laboratory Inspector Leader of the College of American Pathologists.
Dr. La Rosa has a deep interest in our unique prostate mapping biopsy procedure and was instrumental in establishing its validity for accurate staging of early disease. Dr. La Rosa is the main pathologist reviewing most prostatic tissues obtained from our patients, including biopsies and whole prostatectomy specimens, and he is an invaluable resource in our weekly Second Opinion Urologic Cancer Conferences.
Clifford Jones, DDS
Dr. Jones received his dental degree from UCLA in 1977 and then practiced restorative dentistry in Phoenix Arizona for the next 24 years. He was one of the first dentists to utilize the new and exciting phase of implant dentistry in his practice and he was actively involved in several aspects of organized dentistry including many years as a member and chairman of the Peer Review Committee. In a complete change of pace, Dr. Jones and his wife moved to Colorado to be near their son and his family and Dr. Jones joined Dr. Crawford’s prostate cancer team. He helps manage several prostate cancer clinical trials and works closely with our patients who are interested in 3D prostate cancer biopsies and targeted focal cryotherapy for their prostate cancer.
Paul Arangua, B.S.
PRA, Study Coordinator
Department of Urologic Oncology
Education: B.S., University of Colorado
Masters in Public Health (MPH), epidemiology concentration, anticipated spring 2016
Paul is a study coordinator at the University of Colorado and has been part of numerous studies including The Application of Targeted Focal Cryotherapy for the Treatment of Organ Confined Prostate Cancer, The Injection of Botulinum Toxin for the Treatment of Benign Prostatic Hyperplasia, Salvage Cryotherapy Online Registry Evaluation, and several other investigator initiated studies. Currently, Paul works closely on several self-designed, investigator initiated quality of life studies on various prostate and testicular cancer patient cohorts. He has extensive experience using REDcap to design databases and automated-distribution survey instruments. Recently, he has designed an iPad compliant quality of life survey for all 3D prostate cancer biopsy patients. Paul has extensive experience with the ProView software platform, which he uses to perform real-time 3D reconstruction in patients during 3D prostate cancer biopsy. His special interests include database design and data analysis, study design, clinical epidemiology, and minimally invasive prostate cancer diagnostic and treatment procedures including 3D prostate cancer biopsy and Targeted Focal Cryotherapy.
Wendy Poage, MHA
University of Colorado Medical Campus
Prostate Conditions Education Council
Wendy Poage earned her Bachelor of Science degree at the Colorado State University in 1993 and her Masters of Health Care Administration at Webster University in 1997. Wendy has been the President of the Prostate Conditions Education Council since 1998 and the Administrator of Urologic Oncology at the University of Colorado Health Sciences Center for over ten years.